PF-06835919

DRUG4 trials

Sponsors

Pfizer

Conditions

HealthyHealthy VolunteersNon-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis

Phase 1

Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

CompletedNCT02974374

PfizerNon-alcoholic Fatty Liver Disease

Start: 2016-10-31End: 2017-01-31Updated: 2017-12-15

Multiple Ascending Dose and DDI Study

CompletedNCT03031119

PfizerHealthy Volunteers

Start: 2017-01-31End: 2017-07-31Updated: 2017-09-06

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

CompletedNCT04427917

Start: 2020-11-24End: 2021-03-31Updated: 2022-07-21

Phase 2

A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

CompletedNCT03969719

PfizerNon-alcoholic Steatohepatitis

Start: 2019-07-18End: 2021-03-30Updated: 2022-05-11